# Cardiac-Sparing Techniques in Left-Sided Breast Cancer

## Overview

Radiation therapy for left-sided breast cancer inevitably exposes the heart to incidental radiation, which increases the long-term risk of ischemic heart disease and cardiac mortality. The landmark population-based study by Darby and colleagues demonstrated a linear, no-threshold relationship between the mean heart dose and the risk of coronary events, with a 7.4% increase in risk per Gray of radiation received. Modern cardiac-sparing techniques are designed to reduce the mean heart dose to less than 4 Gy, ideally below 2 Gy, while still ensuring adequate coverage of the target breast tissue and regional nodes. The primary strategies to achieve this goal include deep inspiration breath hold (DIBH), prone positioning, optimization of intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT), as well as proton therapy.

## Cardiac Risk from Breast Radiation

### Darby et al. (2013) -- Key Study

Darby et al. conducted a population-based case-control study involving 2,168 women treated with breast radiation therapy in Denmark and Sweden between 1958 and 2001. Their findings revealed that the rate of major coronary events increased linearly with the mean heart dose received during radiation. Specifically, the excess relative risk was 7.4% per Gy of mean heart dose, with a 95% confidence interval ranging from 2.9% to 14.5%. Importantly, the increased risk began within the first five years after radiation therapy and persisted for at least 20 years. There was no apparent threshold dose below which the risk was absent. While pre-existing cardiac risk factors such as diabetes, ischemic heart disease, and smoking increased the absolute risk of cardiac events, they did not alter the relative risk increase per Gy of radiation.

### Cardiac Substructures at Risk

Certain cardiac substructures are more vulnerable to radiation damage. The left anterior descending artery (LAD) is the most susceptible, as it runs in the anterior interventricular groove adjacent to the chest wall and is often within the tangential radiation fields. The left ventricle, particularly its anterior wall, is also at risk, along with the left atrium, right coronary artery (which receives a lower but nonzero dose), and cardiac valves. Emerging data suggest that doses to specific substructures, such as the maximum dose to the LAD and the volume of the left ventricle receiving 5 Gy (V5), may be more predictive of cardiac risk than the mean heart dose alone.

### Who Is at Highest Risk?

Patients with pre-existing cardiac disease or risk factors—including hypertension, diabetes, smoking, and dyslipidemia—are at higher risk of radiation-induced cardiac events. Younger patients with a long life expectancy face decades of latent risk. Those receiving cardiotoxic systemic therapies, such as anthracyclines or trastuzumab, are also more vulnerable. Additionally, patients undergoing regional nodal irradiation (RNI), especially with internal mammary node (IMN) coverage, receive higher cardiac doses and thus have increased risk.

## Deep Inspiration Breath Hold (DIBH)

### Mechanism

DIBH exploits the physiological changes during deep inspiration, when the diaphragm descends and the lungs expand. This expansion pushes the heart inferiorly and posteriorly, increasing the distance between the heart and the tangential radiation fields by 1 to 3 centimeters. As a result, the mean heart dose is reduced by 30% to 60% compared to free-breathing treatment.

### Techniques

Several techniques are used to implement DIBH. The active breathing coordinator (ABC) mechanically holds the patient's breath at a predetermined lung volume. Voluntary DIBH with real-time monitoring employs surface-guided radiation therapy (SGRT) systems, such as AlignRT or Catalyst, which use optical surface monitoring to verify the breath-hold position and trigger the radiation beam. The Real-time Position Management (RPM) system uses an infrared reflective marker placed on the chest wall, gating the beam within a specified displacement window. Spirometry-based breath hold requires the patient to breathe into a spirometer to reach a target lung volume.

### Clinical Results

DIBH reduces the mean heart dose from approximately 4 to 6 Gy during free-breathing to 1 to 3 Gy for whole breast irradiation (WBI) alone. The maximum dose to the LAD decreases from 25 to 40 Gy down to 10 to 20 Gy. When internal mammary node coverage is added, DIBH lowers the mean heart dose from 6 to 10 Gy to 3 to 5 Gy. Most patients tolerate DIBH well, with compliance rates exceeding 90% in published series.

### Patient Selection

DIBH is recommended for all patients with left-sided breast cancer when technically feasible. The greatest benefit is observed when the free-breathing plan results in a mean heart dose exceeding 3 to 4 Gy. Some institutions use a trigger threshold, switching to DIBH if the free-breathing mean heart dose exceeds 2 Gy. Patients unable to hold their breath due to chronic obstructive pulmonary disease (COPD), anxiety, or poor compliance may require alternative cardiac-sparing approaches.

## Prone Positioning

### Mechanism

Prone positioning involves the patient lying face-down, allowing the breast to fall away from the chest wall by gravity. This creates separation between the breast tissue and the heart and lung, reducing cardiac exposure. This technique is most beneficial for women with large breasts, typically cup size C or greater.

### Advantages

In selected patients, particularly those with large breasts, prone positioning reduces the mean heart dose. It also eliminates the anterior skin fold beneath the breast, which reduces skin toxicity, and decreases the dose to the ipsilateral lung. Prone positioning can be combined with DIBH (prone DIBH) to achieve additional cardiac sparing.

### Limitations

Prone positioning may not reduce cardiac dose in women with small breasts, as the breast falls minimally away from the chest wall. Reproducibility of setup can be challenging and requires dedicated prone breast boards. It is generally unsuitable for comprehensive regional nodal irradiation because it is difficult to include supraclavicular and internal mammary nodes in this position. Limitations also include setup reproducibility and availability of image guidance.

## IMRT/VMAT Optimization

### Forward-Planned IMRT (Field-in-Field)

Forward-planned IMRT, or field-in-field technique, uses subfields within the tangent beams to eliminate hot spots and reduce heart dose. This approach is simple, widely available, and effective for whole breast irradiation without nodal coverage. However, it has limited ability to significantly reduce cardiac dose beyond what can be achieved through field design.

### Inverse-Planned IMRT/VMAT

Inverse-planned IMRT and VMAT use multi-beam or arc-based optimization with cardiac dose constraints to achieve superior dose homogeneity and conformality. These techniques are particularly valuable for comprehensive regional nodal irradiation, including breast or chest wall plus supraclavicular and internal mammary nodes, where cardiac avoidance is most challenging. However, they carry the risk of delivering a low-dose bath to larger volumes of lung and heart tissue, and the clinical significance of lung V5 Gy remains debated. Hybrid techniques combine tangent-based IMRT for the breast with a separate VMAT or IMRT plan for nodal volumes to balance dose distribution.

## Proton Therapy

### Dosimetric Advantage

Proton therapy offers a dosimetric advantage due to the Bragg peak phenomenon, which eliminates exit dose through the heart. This allows near-zero cardiac dose even with comprehensive regional nodal irradiation including internal mammary node coverage. Proton therapy also reduces dose to the ipsilateral lung and contralateral breast.

### Current Evidence

There are no randomized trials comparing proton therapy with photon therapy for cardiac outcomes in breast cancer. The RADCOMP trial, which randomized patients to proton versus photon therapy for breast cancer with nodal irradiation and used cardiac events as an endpoint, has closed to accrual and results are pending. Modeling studies suggest that proton therapy could reduce the lifetime absolute risk of cardiac events by 1 to 3% in left-sided breast cancer patients receiving regional nodal irradiation. However, cost and limited availability restrict routine use of proton therapy, which is typically reserved for patients at highest cardiac risk requiring comprehensive nodal coverage.

## Cardiac Dose Constraints

### Commonly Used Constraints

Commonly applied cardiac dose constraints include maintaining the mean heart dose below 4 Gy according to QUANTEC guidelines, with an ideal target of less than 2 Gy when using DIBH. Heart volume receiving 25 Gy (V25) should be kept below 10%, and heart volume receiving 20 Gy (V20) below 5%. The maximum dose to the LAD should be minimized; although no universally accepted constraint exists, a maximum dose below 20 Gy is a reasonable goal. The mean LAD dose should be kept under 10 Gy. Constraints for the left ventricle vary by institution.

| Structure | Metric | Constraint | Source/Note |
|---|---|---|---|
| Heart | Mean dose | < 4 Gy (ideal < 2 Gy with DIBH) | QUANTEC; Darby 7.4%/Gy risk |
| Heart | V25 | < 10% | Institutional guideline |
| Heart | V20 | < 5% | Institutional guideline |
| LAD | Dmax | < 20 Gy (goal) | No universal standard |
| LAD | Mean dose | < 10 Gy | Emerging substructure data |

### Monitoring and Follow-Up

Baseline cardiac assessment is recommended for patients with pre-existing cardiac risk factors. Echocardiography should be considered for patients receiving concurrent cardiotoxic systemic therapies such as anthracyclines or trastuzumab. Long-term management of cardiovascular risk factors—including smoking cessation, lipid control, and blood pressure management—is as important as optimizing radiation techniques. Because radiation-induced cardiac events have a long latency period, often 5 to 20 or more years, long-term follow-up is essential.

<image>A paired anatomical diagram showing the heart-chest wall relationship in free-breathing (left panel) versus deep inspiration breath hold (right panel) for a left-sided breast cancer patient. In free-breathing, the heart (red) contacts the anterior chest wall with the LAD (yellow line) within the tangential field. In DIBH, the diaphragm is displaced inferiorly, the lung volume is expanded (blue), and the heart is displaced 2 cm posteriorly and inferiorly, with the LAD now outside the tangential fields. Mean heart dose values are annotated for each scenario.</image>

<image>A graph reproducing the key finding from the Darby et al. study: the x-axis shows mean heart dose (Gy) and the y-axis shows the relative rate of major coronary events. A linear dose-response line with 95% confidence interval demonstrates the 7.4% increase in coronary events per Gray. Annotated data points indicate typical mean heart doses achievable with different techniques: free-breathing tangents (~4-6 Gy), DIBH (~1-3 Gy), VMAT with DIBH (~1-2 Gy), and proton therapy (~0.5 Gy).</image>

<image>An axial CT comparison at the level of the heart showing dose color-wash for left-sided breast irradiation with regional nodal coverage using four techniques arranged in a 2x2 grid: (A) free-breathing tangents + separate supraclavicular field, (B) DIBH with tangents, (C) VMAT with DIBH, and (D) proton therapy. Heart, LAD, and lung contours are shown. A table below summarizes mean heart dose, LAD max, and V20 lung for each technique.</image>

## Key Clinical Pearls

The Darby study established a linear, no-threshold dose-response relationship for cardiac events following breast radiation therapy, emphasizing that every Gray of mean heart dose matters. Therefore, the goal should be to minimize cardiac dose as much as technically feasible. Among cardiac-sparing techniques, DIBH is the single most impactful; it is well tolerated, widely implementable, and should be offered to all eligible patients with left-sided breast cancer. Prone positioning provides the greatest benefit for large-breasted women receiving whole breast irradiation without nodal coverage but is generally incompatible with comprehensive regional nodal irradiation. When comprehensive nodal irradiation, including internal mammary nodes, is indicated for left-sided tumors, IMRT or VMAT combined with DIBH is the preferred approach. Proton therapy should be considered for patients with pre-existing cardiac risk factors who require comprehensive nodal coverage. Finally, reducing cardiac risk extends beyond radiation technique optimization; managing modifiable cardiovascular risk factors such as smoking, hypertension, and hyperlipidemia in breast cancer survivors is equally critical for long-term cardiac health.

## References

- Darby SC et al. "Risk of ischemic heart disease in women after radiotherapy for breast cancer." *N Engl J Med*. 2013;368(11):987-998.  
- Nissen HD, Appelt AL. "Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients." *Radiother Oncol*. 2013;106(1):28-32.  
- Bartlett FR et al. "The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery." *Br J Radiol*. 2017;90(1071):20160807.  
- Taylor CW et al. "Cardiac structure injury after radiotherapy for breast cancer: cross-sectional study with individual patient data." *J Clin Oncol*. 2017;35(8):875-882.  
- Mast ME et al. "Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?" *Radiother Oncol*. 2013;108(2):248-253.